Cancer Therapy Advisor

Industry Supported Education

Five-Year Extended Follow-Up Results: Dual Immunotherapy as First-line Treatment for Certain Advanced Renal Cell Carcinoma Patients

November 24, 2021

Sponsored by Bristol Myers Squibb For health care professionals (HCPs) treating patients diagnosed with renal cell carcinoma (RCC), finding an effective treatment option can be challenging.1 Historically, the prognosis for RCC patients has been poor with the most recent data (2011-2017) pointing to a five-year survival rate of 13.9% for advanced cases.2 Fortunately, research has…

Asian parent and child patients.

Pediatric Cancer

Parents Report Challenging Relationships With Pediatric Oncology Clinicians

By

Andrea S. Blevins Primeau, PhD, MBA

November 24, 2021

Asian parents were more likely to report challenging relationships.

Patient and doctor

Chronic Lymphocytic Leukemia

Ibrutinib Not Recommended Over ‘Watch and Wait’ in Asymptomatic, Early CLL

By

Sucharita Mistry, PhD

November 24, 2021

Ibrutinib improved event-free survival, but its effect on overall survival is unclear.

Image of glioblastoma.

Adding Nivolumab to Standard Care Does Not Improve Survival in Glioblastoma

By

Jonathan Goodman, MPhil

November 24, 2021

The median PFS was 10.6 months in the nivolumab group and 10.3 months in the placebo group.

Fyarro Approved for Malignant Perivascular Epithelioid Cell Tumor

By

Brian Park, PharmD

November 24, 2021

The approval of Fyarro was based on data from the phase 2 AMPECT study.

Female cancer patient exercising.

Structured Exercise Aids Recovery From Breast Cancer Surgery

November 24, 2021

Upper-limb disability at 1 year decreased with exercise.

Conversation with a patient

General Oncology, News

Blacks, Hispanics Still Underrepresented in Cancer Clinical Trials

November 24, 2021

Between 2015 and 2019, Black and Hispanic patients were underrepresented in trials of colorectal, lung, and prostate cancer.

Hospitalized COVID patient

General Medicine

ICU Bed Occupancy During COVID-19 Linked to Increase in Excess Deaths

November 24, 2021

If ICU bed use reached 75% capacity nationwide, an excess of 12,000 deaths would be expected 2 weeks later.

Female patient.

Men and Women Differ in Their Refusal of Breast Cancer Treatments

By

Andrea S. Blevins Primeau, PhD, MBA

November 23, 2021

The odds of refusing hormone therapy, surgery, and radiation differed by sex.

Image of woman talking to doctor through tablet.

Neuro-Oncology Patient Satisfaction Maintained During COVID-19 Pandemic

By

Leah Lawrence

November 23, 2021

Patient satisfaction scores before the pandemic were comparable to scores during the pandemic.

Next post in Brain Cancer

Elderly patient in a hospital bed.

One-Third of Patients May Not Recover From TMZ-Induced Aplastic Anemia